title: [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
abstract: Hypertension is one of the important risk factors in the pathogenesis of arteriosclerosis. The differences between primary and secondary prevention in diagnosis and therapeutic strategies are reviewed from international studies. The optimal therapy for hypertension and risk stratification, including all other risk factors, will reduce the incidence and mortality of coronary heart disease and stroke.
authors.affiliation: Ambulantes Kardiologisches Rehabilitationszentrum Rolshoverhof Rolshover Str. 526 51105 Köln, Germany.
authors.forename: D B
authors.initials: DB
authors.lastname: Gysan
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000517:prevention & control; D002648:Child; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D010919:Placebos; D015995:Prevalence; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000517:prevention & control; D014944:World Health Organization
chemical_list: D000959:Antihypertensive Agents; D010919:Placebos